NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
$3.04 -0.04 (-1.30%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$3.06 +0.02 (+0.76%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cronos Group Stock (NASDAQ:CRON)

Advanced

Key Stats

Today's Range
$3.02
▼
$3.12
50-Day Range
$3.04
▼
$3.71
52-Week Range
$2.28
▼
$3.91
Volume
1.92 million shs
Average Volume
1.19 million shs
Market Capitalization
$1.11 billion
P/E Ratio
17.88
Dividend Yield
N/A
Price Target
$2.30
Consensus Rating
Buy

Company Overview

Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution.

The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS.

Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.

AI Generated. May Contain Errors.

Cronos Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

CRON MarketRank™: 
2.6688667322 of 5 stars

Cronos Group scored higher than 53% of companies evaluated by MarketBeat, and ranked 353rd out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cronos Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 3 buy ratings, 1 hold rating, and no sell ratings.

  • Downside Risk

    Cronos Group has a consensus price target of $2.30, representing about 24.3% downside from its current price of $3.04.

  • Amount of Analyst Coverage

    Cronos Group has only been the subject of 3 research reports in the past 90 days.

  • Read more about Cronos Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Cronos Group are expected to grow by 62.50% in the coming year, from $0.16 to $0.26 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is 17.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is 17.88, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.56.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.23% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 4.94.
  • Change versus previous month

    Short interest in Cronos Group has recently increased by 4.87%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • News Sentiment

    Cronos Group has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Cronos Group this week, compared to 4 articles on an average week.
  • Search Interest

    Only 4 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    7.80% of the stock of Cronos Group is held by insiders.

  • Percentage Held by Institutions

    8.71% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRON Stock News Headlines

3 Canadian Penny Stocks To Own In November 2026
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
Top 3 Canadian Penny Stocks To Watch In November 2026
Canadian Penny Stocks To Watch In November 2026
Top 3 Canadian Penny Stocks To Watch In November 2026
See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at $2.63 at the beginning of the year. Since then, CRON stock has increased by 15.6% and is now trading at $3.04.

Cronos Group Inc. (NASDAQ:CRON) issued its quarterly earnings data on Thursday, November, 5th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.01. The firm had revenue of $63.45 million for the quarter, compared to analysts' expectations of $51.15 million. Cronos Group had a net margin of 28.04% and a trailing twelve-month return on equity of 2.56%.
Read the conference call transcript
.

Cronos Group's top institutional investors include Cibc World Market Inc. (0.35%), Silver Oak Securities Incorporated (0.19%), Goldman Sachs Group Inc. (0.18%) and HighTower Advisors LLC (0.10%).
View institutional ownership trends
.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray Brands (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU) and Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CRON
CIK
1656472
Fax
N/A
Employees
610
Year Founded
2013

Price Target and Rating

High Price Target
$2.30
Low Price Target
$2.30
Potential Upside/Downside
-24.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.17
Trailing P/E Ratio
17.88
Forward P/E Ratio
11.69
P/E Growth
N/A
Net Income
-$9.45 million
Net Margins
28.04%
Pretax Margin
29.19%
Return on Equity
2.56%
Return on Assets
2.43%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.71
Quick Ratio
11.91

Sales & Book Value

Annual Sales
$206.20 million
Price / Sales
5.40
Cash Flow
$0.01 per share
Price / Cash Flow
242.48
Book Value
$3.07 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
366,471,000
Free Float
337,886,000
Market Cap
$1.11 billion
Optionable
Optionable
Beta
0.96

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:CRON) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners